← Back to Search

Skin Barrier Oral Supplement for Rosacea

N/A
Recruiting
Research Sponsored by Integrative Skin Science and Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males and females 30 to 70 years of age
Be older than 18 years old
Must not have
Unwillingness to discontinue oral supplementation, or supplement ingredients found in the study's oral product 1 month prior to enrollment
Use of finasteride or dutasteride
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how taking supplements can improve skin and gut health in people with rosacea.

Who is the study for?
This trial is for men and women aged 30-70 with mild to moderate rosacea and signs of inflammation (hs-CRP >= 1.0 mg/L). Participants should not have used oral antibiotics or changed hormonal therapies recently, must agree to stop certain supplements and skin treatments before the study, and cannot be pregnant, breastfeeding, or current/recent smokers.
What is being tested?
The study tests an oral supplement designed to improve skin barrier function and reduce systemic inflammation in people with rosacea. It aims to see if this supplement can alter both the skin's condition and gut health positively.
What are the potential side effects?
Potential side effects are not detailed here but may include reactions related to L-Histidine or antioxidants present in the supplement. These could range from digestive discomforts to allergic responses depending on individual sensitivities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 70 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am willing to stop taking my current supplements 1 month before joining the study.
Select...
I am taking finasteride or dutasteride.
Select...
I am currently smoking or have smoked significantly in the past.
Select...
I have taken oral antibiotics in the last month.
Select...
I have been diagnosed with severe rosacea.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Blood hs-CRP level
Digestive Questionnaire
Fecal levels of calprotectin
+3 more
Other study objectives
Facial erythema
Inflammatory lesions on the face

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Skin Barrier Oral SupplementExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Integrative Skin Science and ResearchLead Sponsor
32 Previous Clinical Trials
1,950 Total Patients Enrolled
1 Trials studying Rosacea
150 Patients Enrolled for Rosacea
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top